Cottone et al, Feeding microstructure in high-fat diet-fed DR and DIO rats

Centrally administered urocortin 2 decreases gorging on high-fat diet in genetically prone diet-induced obese rats

Pietro Cottone, Ph.D.1,2,3*; Valentina Sabino, Ph.D.1,2,3*; Tim R. Nagy, Ph.D. 4; Donald V. Coscina, Ph.D.5; Barry E. Levin, M.D.6, 7; Eric P. Zorrilla, Ph.D. 1,3

1Committee on the Neurobiology of Addictive Disorders, The Scripps Research Institute, La Jolla, CA, USA; 2Laboratory of Addictive Disorders, Departments of Pharmacology and Psychiatry, Boston University School of Medicine, Boston, MA, USA; 3Harold L. Dorris Neurological Research Institute, The Scripps Research Institute, La Jolla, CA, USA; 4Department of Nutrition Sciences, University of Alabama at Birmingham, Birmingham, AL, USA; 5 Departments of Psychology, and Nutrition & Food Sciences, College of Liberal Arts & Sciences, and Departments of Psychiatry & Behavioral Neurosciences, and Internal Medicine, School of Medicine, Wayne State University, Detroit, MI, USA; 6Neurology Service (127C), VA Medical Center, East Orange, New Jersey, USA, 7Department of Neurology and Neurosciences, New Jersey Medical School, UMDNJ, Newark, New Jersey, USA

*These authors equally contributed to this work.

Correspondence and requests for materials should be addressed to:

Pietro Cottone (Email: )

Laboratory of Addictive Disorders, Departments of Pharmacology and Psychiatry

Boston University School of Medicine

72 E Concord St, R-618

Boston, MA 02118 USA

Phone: 617-638-5662 / Fax: 617-638-5668

and

Eric P. Zorrilla (Email: )

Committee on the Neurobiology of Addictive Disorders, SP30-2400

The Scripps Research Institute

10550 N. Torrey Pines Road

La Jolla, CA 92037 USA

Phone: 858-784-7416 / Fax: 858-784-7405

Supplementary materials and methods

Subjects

Male genetically-selected Diet-Induced Obesity (DIO) (n=10) and Diet Resistant (DR) (n=10), offspring of rats from the original colonies of DIO and DR rats bred by Levin et al (Levin et al., 1997), were born at The Scripps Research Institute. Rats were maintained in a 12:12 hr reverse-lighting cycle in a humidity- (60%) and temperature-controlled (22 °C) vivarium. Rats had access to Harlan Teklad LM-485 Diet 7012 chow (65.0% of kcal from carbohydrate, 13.0% from fat, and 21.0% from protein; energy = 3.1 kcal/g; Harlan Teklad, Indianapolis, IN) and water ad libitum before the beginning of experiments. Procedures adhered to the National Institutes of Health Guide for the Care and Use of Laboratory Animals (NIH Publication number 85-23, revised 1996) and the “Principles of laboratory animal care” ( and were approved by the Institutional Animal Care and Use Committee of The Scripps Research Institute.

Drugs

Rat Urocortin 2 (Ucn 2) and angiotensin II, generously provided by Dr. Jean Rivier (The Salk Institute, La Jolla, CA), were synthesized by solid-phase methodology and characterized as previously described 1, 2. Ucn 2 was freshly dissolved in sterile water and then diluted with phosphate-buffered saline (PBS) to attain the desired concentrations in a final vehicle of 0.5X PBS (pH=7.4). Angiotensin II was dissolved in 1X PBS (pH=7.4).

Intra-cranial surgery and injection procedures

Cannulae were directed at the third ventricle 3 because type 2 urocortins are known to suppress food intake at least in part via hypothalamic sites of action 3, 4. Anesthetized (isoflurane, 2–3% in oxygen) subjects were each stereotaxically (David Kopf Instruments, Tujunga, CA, USA) implanted with a single stainless steel, 24-gauge guide cannula (Plastics One, Inc., Roanoke, VA, USA) above the third ventricle (3v), terminating 3 mm above the final injection site. Each cannula was positioned 0.8 mm posterior to bregma on the midline, terminating 3.5 mm below the outer surface of the skull with the interaural bar set at flat skull (dorsal/ventral: bregma=lamda). Validated coordinates 3, 5 were based on the atlas of Paxinos and Watson 6. A dummy stylet (Plastics One) maintained patency.

For testing, drug solutions or vehicle (2 µl) were injected manually over 90 sec with a Hamilton microsyringe linked by PE 20 tubing to a 31-gauge stainless steel injector projecting 3 mm beyond the tip of the guide cannula. Injectors were left in place for 1 additional min for diffusion. Rats were maintained in familiar holding cages during the pretreatment interval and then returned to their enclosures, with monitoring of nose-pokes beginning immediately. Cannula placements were functionally verified at the conclusion of all testing as a positive dipsogenic response (>5 ml water intake within 30 min) to 3v angiotensin II (100 ng/2 µl).

Microstructural analysis of ingestion

Apparatus

To study the microstructure of ingestion, rats were individually housed in Plexiglas test cages (22×22×35 cm) equipped for this purpose 7, 8. Rats obtained individual 45-mg pellets from a trough replenished by an automated dispenser (Med Associates, St. Albans VT). Inside the enclosure rats were first trained using a chow diet (45 mg precision 5TUM: carbohydrate 65.5% (kcal), fat 10.4%, protein 24.1%, 3.7 kcal g−1;Test Diet/Purina Mills, Inc., Richmond, IN, USA), but ultimately tested with a high-fat diet. The microstructure high-fat diet (F56381: fat 34.9% [kcal], carbohydrate 46.4%, protein 18.7%, 4.2 kcal/g; Bioserv, Frenchtown, NJ) was a 45-mg precision-pelleted variation of the high-fat diet that rats consumed in their home cages (D12266B). The acquisition of a pellet was detected by photobeam interruptions (0.5 sec duration) caused by the rat opening a freely swinging door to access the pellet in the trough. An additional pellet was not delivered until the door returned to its neutral position and a 3.25 sec timeout period elapsed, to prevent duplicate pellet deliveries 3 and allow the study of feeding with pellet-to-pellet resolution. Water delivery (0.1 ml) into a reservoir was governed by a response-contingent solenoid (W.W. Grainger, Lincolnshire, IL) activated by nose-poke interruption (0.5 s) of photobeams monitoring a separate hole, with a 1-sec timeout period to prevent duplicate deliveries. Responses were recorded by a computer with 10 msec resolution 9, 10.

Study design

Beginning from 50 days of age, DR and DIO rats were provided only a high-fat diet in their home cages (D12266B, 32.0% fat [kcal], 51.0% carbohydrate, 17.0% protein; 4.4 kcal/g; Research Diets, New Brunswick, NJ) unless otherwise specified. Rats learned how to obtain food and water in the microstructure enclosures beginning from 110-120 days of age. During this period, rats lived in the microstructure enclosures continuously except for brief periods (30 min) immediately before the dark cycle onset, when they were removed for apparatus maintenance. The dark cycle and test sessions began at 10:00AM. After establishing stable daily food and water intakes (12-13 sessions), rats were returned to their home cages for chronic diet exposure. At 218 days of age, rats were implanted with the 3v guide cannulae and allowed to recover for one week. Microstructure sessions resumed at 226 days of age. After re-attainment of stable food intake (12-13 sessions), rats were provided high-fat diet access in the enclosure. After high-fat diet intakes stabilized (<15% food intake variation across 3 consecutive days), spontaneous baseline high-fat diet intake and meal microstructure of DIO vs. DR high-fat rats were measured at 241 and 242 days of age. To determine the effects of acute central Ucn 2 administration on high-fat diet intake, rats then received 0, 0.1, 0.3, 1, or 3 µg doses, 10 min before testing. Doses, based on previous studies 3, 11, 12, were given using a within-subject Latin square design with 1-2 intervening treatment-free days beginning from 244 days of age. Food and water intakes were monitored as nosepoke responses for 23.5 hr.

Meal pattern analysis

Microstructure analysis used a meal definition that recognizes the existence of prandial drinking within meals 13. For both genotypes, this analysis revealed two distinct peak distributions of log-normal (ln)-transformed interfeeding intervals (IFI), a much larger, faster distribution of intra-meal intervals and a slower distribution of between-meal intervals. A value that lay between both distributions for both genotypes (300 sec between feeding or drinking events) was defined as the threshold intermeal interval (IMI) 3. Meals were defined to contain a minimum of 0.09 g of food (2 pellets), and descriptive statistics of average nocturnal and diurnal meal structure were calculated separately. Parameters included the number of meals, the average size and duration of meals, and the average IMI. Overall meal duration was calculated as the total interval from the first to last response of a meal, and duration of eating (or drinking) within the meal was calculated as the sum of the durations of bursts of eating (or drinking) where the duration of each burst was defined as the interval from the first to the last consecutive response for food (or water). Thus, transitions between eating and drinking were included in total meal duration, but not in the duration of eating or drinking. Meal sizes for eating and drinking were calculated separately as the average number of food- or water-directed responses during meals. The IMI was defined as the interval from the last response of a meal to the first response of the next meal.

Within-meal microstructure analysis

To identify differences between high-fat diet-fed DR and DIO rats in the rate and regularity of sustained eating within meals, analysis of the ln-transformed duration of consecutive (uninterrupted by drinking) within-meal IFIs was performed 3, 8. The mean, standard deviation, kurtosis, skewness and histogram entropy of the ln-transformed duration of each subject’s consecutive IFIs was individually determined and then averaged across subjects. Histograms were constructed from ln-transformed IFI durations that fell from e1 to e3 sec (~2.7-20.1 sec), with a bin width of e0.1. Significant increases in the standard deviation (a measure of continuous variability, reflected in the horizontal spread of the histogram) or the histogram entropy (a measure of categorical variability, reflected in an increasing number of populated histogram bins, each with more similar event frequencies) would indicate a decreased regularity of intake. Conversely, a decrease in the kurtosis of the inter-pellet interval distribution (a measure of the distribution's 'peakedness’, reflected in a flatter top and taller tails of the distribution) would be consistent with a decreased regularity of pellet-to-pellet feeding within meals 3. Finally a significant increase in the positive skewness (a measure of the distribution’s right-tailed asymmetry) would be consistent with an increase in the relative frequency of fast pellet-to-pellet intake.

Fat pad and body composition analysis

Two days after completing the Ucn 2 study, animals were euthanized (262 days of age), and their frozen carcasses were shipped to the University of Alabama at Birmingham for chemical analysis of body composition. Carcasses were thawed (room temperature) and weighed to determine freezing-related water loss. Gastrointestinal tracts were removed to determine eviscerated weight. Visceral (gonadal, retroperitoneal, mesenteric) and non-visceral (inguinal, subcutaneous) white fat pads and brown adipose tissue (BAT) were dissected, weighed, and returned to the carcass for composition analysis. Total body water, fat mass, and fat-free dry mass (FFDM) were determined 14.

Statistical analysis

To compare the time courses of ingestion by DR and DIO rats, split-plot analyses of variance (ANOVAs) were performed on the incremental average nocturnal and diurnal intake of food during 1-hr time bins from the two baseline days, with Genotype as a between-subjects factor and Time as a within-subject factor. Student’s t-tests were used to identify genotype differences in the meal microstructure of food intake and inter-pellet interval frequency histogram measures within the dark and light cycles.

To compare the time course of Ucn 2 anorexia between high-fat diet fed DIO and DR rats, a three-way mixed ANOVA was performed on the incremental intake of food during 1-hr time bins, with Dose and Time as within-subject factors and Genotype as a between-subjects factor. Meal pattern and inter-pellet interval frequency histogram measures were analyzed by split-plot ANOVA with Dose as a within-subject factor, and Genotype as a between-subjects factor. Linear contrasts were performed to determine whether Ucn 2 treatment exerted a log-linear, dose-response effect on measures of ingestion. In all analyses, intermeal interval durations were transformed to logarithmic values to account for the ln-normal time scale of post-meal intervals 3, 13, 15.

To compare the degree to which fat pad and whole carcass fat weights were disproportionately increased (after controlling for differences in lean body mass), analysis of covariance (ANCOVA) was used 16, with the fat measure as the dependent measure, genotype as the between-subjects factor and non-fat mass as a covariate. To allow comparison with other work, fat pad mass and whole carcass fat also were expressed as a percentage of body weight and analyzed by Student’s t test.

For interpretation of main effects of repeated measures with more than two levels (e.g., Dose), post hoc pair-wise comparisons were performed within the general linear model. Student’s unpaired t-tests were used for between-subject factors having only two levels. The software packages used were Systat 11.0 (SPSS, Chicago, IL, USA), Excel 2003 (Microsoft, Redmond, WA, USA), SigmaPlot 11.0 (Systat Software, Inc., Point Richmond, CA, USA), and InStat 3.0 (GraphPad, San Diego, CA, USA).

Supplementary Table 1

Table 1. Differences in baseline prandial intake of high-fat diet-fed genetically selected DR and DIO rats
Parameter
Dark Phase / Light Phase
DR / DIO / DR / DIO
Feeding
Intake (g) / 22.9±1.1 / 22.3±1.3 / 6.8±0.5 / 6.6±0.8
Duration (min) / 73.0±5.1 / 57.8±5.9 / 22.8±1.7 / 17.4±1.6 *
Drinking
Intake (ml) / 15.0±2.2 / 4.8±0.6 *** / 4.0±0.6 / 1.8±0.3 **
Duration (min) / 32.0±4.1 / 15.9±2.7 ** / 10.8±1.8 / 6.0±1.4

Prandial feeding and drinking of genetically-selected diet-induced obesity-resistant (DR) and susceptible (DIO) rats (n=10/genotype) fed a high-fat diet. Data represent the M±SEM quantity or duration of food and water intake within meals of male DR and DIO rats during the dark cycle and the light cycle and were calculated from the average of two consecutive sampling periods measured at 241-242 days of age. Symbols denote significant differences: * p<0.05 compared to DR rats, ** p<0.01, *** p<0.001, (unpaired Student’s t-test).

Supplementary Table 2

Table 2. Effects of i.c.v Ucn 2 on 12h meal microstructure in high-fat diet-fed genetically-selected DR and DIO rats
Parameter
DR / DIO
Feeding
Meal Frequency (meals) ##
0 µg / 7.3±0.2 / 5.1±0.2
0.1 µg / 6.4±0.1 / 4.4±0.1
0.3 µg / 5.9±0.1 / 4.3±0.1
1 µg / 5.9±0.1 / 4.4±0.2
3 µg / 6.4±0.2 / 4.7±0.2
Avg Intermeal Interval (min)
0 µg / 102.7±2.9 / 188.8±16.9
0.1 µg / 111.4±1.8 / 177.7±5.5
0.3 µg / 134.2±7.0 / 157.2±4.4
1 µg / 119.0±2.7 / 144.0±5.1
3 µg / 136.5±7.3 / 165.0±9.2
Drinking
Avg Meal Size (ml) ##
0 µg / 2.5±0.2 / 0.9±0.1
0.1 µg / 2.2±0.1 / 0.9±0.1
0.3 µg / 2.3±0.2 / 1.5±0.1
1 µg / 2.0±0.1 / 1.1±0.1
3 µg / 1.7±0.1 / 0.9±0.1
Avg Meal Duration (min)
0 µg / 4.3±0.2 / 3.5±0.1
0.1 µg / 3.7±0.1 / 3.6±0.3
0.3 µg / 3.4±0.2 / 4.1±0.4
1 µg / 3.4±0.2 / 3.2±0.2
3 µg / 3.5±0.2 / 2.7±0.2
Drinking Rate (µl/sec) ###
0 µg / 9.9±0.4 / 4.5±0.2
0.1 µg / 10.0±0.3 / 4.0±0.1
0.3 µg / 11.2±0.3 / 7.3±0.3
1 µg / 11.0±0.4 / 8.0±0.6
3 µg / 8.5±0.3 / 5.8±0.3

Effect of third ventricle Ucn 2 treatment on nocturnal meal microstructure of genetically-selected diet-induced obesity-resistant (DR) and susceptible (DIO) rats (n=10/genotype) fed a high-fat diet. Data express the M±SEM quantity or duration of food and water intake within meals of adult male DR and DIO rats during the first 12 hr of the dark cycle following Ucn 2 pretreatment. Subjects were pretreated (-10 min) with Ucn 2 in a balanced Latin square design with test sessions beginning at the onset of the dark cycle. ## Genotype main effect p<0.01, ### p<0.001

Supplementary Table 3

Table 3. Adiposity in high-fat diet-fed genetically-selected DR and DIO rats
Parameter
DR / DIO
Fat Pads
White fat pad, g
Total / 43.4±3.1 / 107.1±15.8 ***
Inguinal / 11.6±0.8 / 29.6±3.7 ***
Gonadal / 8.2±0.4 / 14.3±1.7 **
Retroperitoneal / 9.0±0.8 / 26.4±5.3 **
Mesenteric / 7.3±0.6 / 16.9±2.2 ***
Subcutaneous / 7.4±0.8 / 20.0±3.5 **
Brown fat pad, g / 0.56±0.05 / 0.90±0.06 ***
Whole Carcass Adiposity
Fat, g / 47.1±3.2 / 121.6±17.6 ***

Raw fat pad and whole carcass fat weights in high-fat diet fed DR and DIO rats (n=10 rats/genotype). Values are M±SEM. Symbols denote significant differences: * p<0.05 compared to DR rats, ** p<0.01, *** p<0.001, (Student’s t-test).

Supplementary Table 4

Table 4. Comparison of variables related to the microstructure of feeding between genetically-selected DIO rats relative to DR rats in pre- and post-obese states
Parameter / Pre-obese state (Low-fat diet) / Post-obese state (High-fat diet)
Total food intake / ↔ / ↔
Meal size / ↓ / ↑
Meal duration / ↓ / ↔
Meal frequency / ↑ / ↓
Intermeal Interval / ↓ / ↑
Eating rate / ↑ / ↑
Total water intake / ↓ / ↔

Differences in variables related to the microstructure of food intake between genetically-selected DR and DIO rats in a pre-obese state (fed a low-fat chow diet) and in a post-obese state (fed a high-fat diet). Symbols denote relative increase ↑, decrease ↓, or no change ↔ compared to DR. The findings of both the pre-obese state 3 and the post-obese state were obtained using the same validated drinking-inclusive meal definition 17.

Supplementary References

1.Reyes TM, Lewis K, Perrin MH, Kunitake KS, Vaughan J, Arias CA et al. Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc Natl Acad Sci U S A 2001; 98(5): 2843-8.

2.Rivier J, Gulyas J, Kirby D, Low W, Perrin MH, Kunitake K et al. Potent and long-acting corticotropin releasing factor (CRF) receptor 2 selective peptide competitive antagonists. Journal of medicinal chemistry 2002; 45(21): 4737-47.

3.Cottone P, Sabino V, Nagy TR, Coscina DV, Zorrilla EP. Feeding microstructure in diet-induced obesity susceptible versus resistant rats: central effects of urocortin 2. The Journal of physiology 2007; 583(Pt 2): 487-504.

4.Fekete EM, Inoue K, Zhao Y, Rivier JE, Vale WW, Szucs A et al. Delayed satiety-like actions and altered feeding microstructure by a selective type 2 corticotropin-releasing factor agonist in rats: intra-hypothalamic urocortin 3 administration reduces food intake by prolonging the post-meal interval. Neuropsychopharmacology 2007; 32(5): 1052-68.

5.Wren AM, Small CJ, Fribbens CV, Neary NM, Ward HL, Seal LJ et al. The hypothalamic mechanisms of the hypophysiotropic action of ghrelin. Neuroendocrinology 2002; 76(5): 316-24.

6.Paxinos G, Watson, C. The Rat Brain in Stereotaxic Coordinates, Second edn Academic Press: Orlando, 1986.

7.Zorrilla EP, Inoue K, Valdez GR, Tabarin A, Koob GF. Leptin and post-prandial satiety: acute central leptin more potently reduces meal frequency than meal size in the rat. Psychopharmacology (Berl) 2005; 177(3): 324-335.

8.Cottone P, Sabino V, Steardo L, Zorrilla EP. FG 7142 specifically reduces meal size and the rate and regularity of sustained feeding in female rats: evidence that benzodiazepine inverse agonists reduce food palatability. Neuropsychopharmacology 2007; 32(5): 1069-81.

9.Cottone P, Sabino V, Roberto M, Bajo M, Pockros L, Frihauf JB et al. CRF system recruitment mediates dark side of compulsive eating. Proc Natl Acad Sci U S A 2009; 106(47): 20016-20.